Jeff Fairman - 05 May 2022 Form 4 Insider Report for Vaxcyte, Inc. (PCVX)

Role
VP, Research
Signature
/s/ Ron A. Metzger, Attorney-in-Fact
Issuer symbol
PCVX
Transactions as of
05 May 2022
Net transactions value
-$22,914
Form type
4
Filing time
09 May 2022, 16:35:04 UTC
Previous filing
07 Apr 2022
Next filing
24 May 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PCVX Common Stock Sale $22,914 -888 -0.27% $25.80 325,339 05 May 2022 By Fairman Family Trust F1, F2
holding PCVX Common Stock 16,629 05 May 2022 Direct
holding PCVX Common Stock 50,000 05 May 2022 By AF 2020 Irrevocable Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan.
F2 The price reported is a weighted-average price. The shares were sold at prices ranging from $25.58 to $26.19. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.